Clinical Trial Update: ACCELERATE: Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Pegfilgrastim and Darbepoetin Alfa Support for the Treatment of Women With Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a doxorubicin/cyclophosphamide regimen followed by paclitaxel with pegfilgrastim and darbepoetin alfa support in women with breast canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• ARANESP (DARBEPOETIN ALFA)
• Adriamycin (doxorubicin)
• Cytoxan (cyclophosphamide)
• NEULASTA (pegfilgrastim)
• Taxol (paclitaxel)

Snippet

Sponsor: Amgen | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED